Richard Lowenthal

person
1 mentions 1 recordings first heard Nov 2025 last heard 13 Nov ↑1 vs the 12 months before

Richard Lowenthal is the CEO of ARS Pharmaceuticals, involved in developing nasal spray treatments.

Trend

mentions per week · public audio 7d30d6M12M
1 · 13 Nov SepDecMarJunnow

Peak in the week of 13 Nov — 1 mentions across 1 series.

Moments

newest first · ▶ plays the moment
Ann Hunter-Van KirkVanguards of Healthcare by Bloomberg Intelligence · ARS Pharma’s Clinical Differentiation · 0:58 · 13 Nov
…I'm Anne Hunter-Van Kirk, Senior Biopharmaceuticals Analyst at Bloomberg Intelligence, the in-house equity research division of Bloomberg, and I'm very pleased to welcome today's guest, Richard Lowenthal, CEO of ARS Pharmaceuticals.…
· Open transcript →
All 1 moments